Pharma in Brief

FEBRUARY 8, 2024

The Notice advises that if an innovative drug is categorized as “Dormant” in Health Canada’s Drug Product Database, then a generic manufacturer can compare its drug against an alternate CRP, which could include another generic drug, when filing an Abbreviated New Drug Submission ( ANDS ).

Production 52

Production Generic Drugs Drugs Bioequivalency 52

XTalks

MARCH 15, 2024

Amazon Pharmacy says it is focused on transparent pricing and affordability of both branded and generic drugs. It also introduced a feature that allows users to use coupons at checkout to get manufacturer discounts on brand name medications. If you want your company to be featured on Xtalks.com, please email ayeshar@xtalks.com.

Pharmacy 111

Pharmacy Drugs Insulin Branding 111

FDA Law Blog

MARCH 6, 2024

Charles assists clients across a range of FDA-related regulatory matters by providing timely strategic advice on new drug and biologic development and helping them tackle complex regulatory issues.

Cosmetics 59

Cosmetics Compliance Generic Drugs Regulation 59

Pharmaceutical Technology

JULY 10, 2008

As the blockbuster drugs of the 90s that earned the industry billions reach their patent shelf lives, pharmaceutical companies require new medicines to sustain an estimated $157bn worth of sales.

Medicine 100

Medicine Clinical Trials Clinical Trials Development 100

Pharma in Brief

AUGUST 9, 2021

Rolling submissions, which are currently in use for COVID-19 drugs, would be extended to other drugs, such as those which address significant new and emerging infectious diseases in Canada, or which treat, prevent, or diagnose serious or severely debilitating diseases or conditions. Biologic Drugs.

Regulation 98

Regulation Drugs Manufacturing Production 98

XTalks

FEBRUARY 8, 2021

In order to fact-check some of these misconceptions, the US Food and Drug Administration (FDA) recently hosted a webinar on biosimilar and interchangeable biological products to help healthcare professionals understand more about these treatment options. Biosimilars are the “generic” drugs of the biopharma world.

Production 78

Production Insulin Branding Generic Drugs 78

XTalks

JUNE 16, 2023

The current shortage demonstrates how profits in the generic drug market can send shocks through the supply chain, creating a ripple effect that impacts the healthcare system and patients relying on these lifesaving treatments​​.

Drugs 98

Drugs Manufacturing Clinical Supply Chain Clinical Trials 98

XTalks

JUNE 8, 2022

Novartis’ biosimilars and generics drug division Sandoz has announced a new global campaign called ‘Act4Biosimilars’ to help raise awareness about biosimilars and increase their adoption by at least 30 percent in over 30 countries by the year 2030.

Generic Pharmaceutical 69

Generic Pharmaceutical Production Medicine Branding 69

Pharma in Brief

NOVEMBER 5, 2023

According to the Ontario government, if implemented, the amendments would remove barriers in the Formulary approval process and “improve Ontarians’ access to publicly funded drugs under the ODB program and lower cost generic drugs”. Comments to the Ministry of Health are due December 3, 2023.

Drugs 52

Drugs Regulation Production Generic Drugs 52

Pharma in Brief

APRIL 29, 2021

The lowest price method applies where two or more drugs of the same generic name are listed on the List of Medications, subject to several exceptions such as where a patient is allergic to a non-medicinal ingredient found in the generic drug but not in the brand drug.

Manufacturing 52

Manufacturing Drugs Regulation Branding 52

XTalks

AUGUST 2, 2023

With Blackstone Life Sciences, up to €300 million (around $315 million USD) will be invested to accelerate pivotal studies and clinical development programs for formulating the subcutaneous delivery of the anti-CD38 antibody Sarclisa (isatuximab) for the treatment of multiple myeloma. 21) Merck KGaA By: Ayesha Rashid, Ph.D.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

JANUARY 31, 2023

The list of available medicines includes about 50 generic drugs. Through RxPass, Prime members have access to medications that treat more than 80 common health conditions, including acid reflux, high blood pressure and anxiety. The program also offers 24/7 assistance provided by pharmacists or support staff.

Pharmacy 52

Pharmacy Drugs Branding Generic Drugs 52

XTalks

SEPTEMBER 20, 2023

Cost Plus Drugs Initiative by Mark Cuban The Mark Cuban Cost Plus Drug Company is a public-benefit corporation launched by billionaire entrepreneur Mark Cuban with a mission to improve public health by revolutionizing pharmaceutical industry operations.

Pharmacy 64

Pharmacy Drugs Manufacturing Generic Drugs 64

XTalks

FEBRUARY 5, 2024

In the dynamic landscape of oncology therapeutics, understanding the trends and performances of leading drugs is crucial for stakeholders across the healthcare and life sciences sectors. Read on to learn more about the top 40 best-selling oncology drugs in 2023, based on 2022 sales data.

FDA Approval 101

FDA Approval Drugs Sales Development 101

The Pharma Data

JANUARY 27, 2021

CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (“ XPhyto ” or the “ Company “) is pleased to announce its drug formulation and delivery business strategy and milestones for 2021. Further, Vektor is currently engaged in the development of a sublingual drug formulation for a major European generic drug company.

Drugs 52

Drugs Manufacturing Drug Delivery Production 52

Pharma in Brief

JUNE 21, 2020

They include: (1) new factors for assessing excessive pricing, (2) new powers to collect information regarding these factors, (3) new obligations to report indirect price adjustments, (4) risk-based reporting obligations for OTC and generic drugs, and (5) a revised list of international price comparator countries (the PMPRB11 ).

Medicine 40

Medicine Regulation Sales Generic Drugs 40

Delveinsight

FEBRUARY 5, 2021

Moreover, the generic drugs of Zyban are also approved, while for Chantix, its patent is soon going to expire in 2021 in the EU and in 2022 in Japan. Generics in the Market. Whenever the branded drugs go off-the-market, it paves the way for the entry of generics in the market.

Marketing 52

Marketing FDA Approval Branding Production 52

Pharma in Brief

JANUARY 9, 2022

The proposed amendments to the PM(NOC) Regulations would also allow patents claiming different salt forms of medicinal ingredients to be eligible for inclusion on the patent register.

Regulation 52

Regulation Manufacturing Drugs Medicine 52

The Pharma Data

JANUARY 17, 2021

As a bioscience accelerator at the leading-edge of the life science industry, XPhyto will target growth through commercialization of existing products and focused investment in impact driven innovation with the potential for extreme value creation.

Production 40

Production Development Drug Delivery Drugs 40

XTalks

FEBRUARY 5, 2024

In the dynamic landscape of oncology therapeutics, understanding the trends and performances of leading drugs is crucial for stakeholders across the healthcare and life sciences sectors. Read on to learn more about the top 40 best-selling oncology drugs in 2023, based on 2022 sales data.

FDA Approval 52

FDA Approval Drugs Sales Development 52

Pharmaceutical Technology

MAY 3, 2023

Since 2015, the US Food and Drug Administration (FDA) has approved more than 450 “first generics” or the first generic equivalent for a branded drug. These medicines comprise about 10% of all generics approved each year. Still, the FDA does prioritize the review of submissions for first generics.

Generic Drugs 246

Generic Drugs Branding Drugs Production 246

XTalks

AUGUST 30, 2022

Whether you are a director, manager or hold a C-suite role within a pharma, biotech, medical device or life science organization, it is important to understand which leadership styles are currently gaining much influence in the industry. Visionary Leadership. A visionary sees what no one else can see especially in the present time.

Life Science 105

Life Science Generic Drugs Drug Delivery Compliance 105

XTalks

JANUARY 23, 2025

In its second interim staff report released January 14, 2025, the Federal Trade Commission (FTC) revealed that the top three pharma benefit managers (PBM) in the US inflated prices of specialty generic drugs over the past several years, resulting in them raking in billions of dollars in profits. billion in 2021.

Drugs 59

Drugs Generic Drugs Pharmacy Insulin 59

XTalks

SEPTEMBER 14, 2020

In fact, in a report by Eric Reguly on March 4, 2020 in the Globe and Mail, Rosemary Gibson, co-author of China Rx: Exposing the Risks of American’s Dependence on China for Medicines , observed that 80% of the core components that go into generic drugs sold in the US are made in China.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92